Holly Uppal

Doctor of Osteopathic Medicine,  Cleveland Clinic 

Location: Africa

Consulting Services

Case Consulting Legal Support Biostatistics Journal Manuscript Scientific Writing

Areas Of Interest

Borderline Personality Disorders Critical Pathways Kineret Prostaglandin Endoperoxide Analogs Subunit G-Protein, G12 Cerebral Hernia DNA Damage Nucleus Medialis Dorsalis Phosphoenolpyruvate Glycose Phosphotransferase System Coliphage Hybrid Renal Replacement Therapy Compounds, Nitrogen Mustard Visual Auditory Spatial Processing Receptors, alpha-v beta-3 Integrin Antigens, 2H4 Anesthetic Hypnosis X-Ray Therapies Abortifacients Larrea Learning Disorder, Specific Coyotillos Factor, Ciliary Neurotrophic

Professional Narrative

Dr. Holly Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Director Medicine, Amgen 1998
Director Medicine, Harvard Med 1990

Education

Bachelor of science in nursing, Yale School of Medicine 2010
Bachelor of science in nursing, Harvard Medical School 1994

Referees


Publications

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :